Literature DB >> 10438530

Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human fcalpha receptor (FcalphaR) CD89.

R J Pleass1, J I Dunlop, C M Anderson, J M Woof.   

Abstract

Cellular receptors for IgA (FcalphaR) mediate important protective functions. An extensive panel of site-directed mutant IgAs was used to identify IgA residues critical for FcalphaR (CD89) binding and triggering. Although a tailpiece-deleted IgA1 was able to bind and trigger CD89, antibodies featuring CH3 domain exchanges between human IgA1 and IgG1 could not, indicating that both domains but not the tailpiece are required for FcalphaR recognition. To further investigate the role of the interdomain region, numerous IgA1s, each with a point substitution in either of two interdomain loops (Leu-257-Gly-259 in Calpha2; Pro-440-Phe-443 in Calpha3), were generated. With only one exception (G259R), substitutions produced either ablation (L257R, P440A, A442R, F443R) or marked reduction (P440R) in CD89 binding and triggering. Further support for involvement of these interdomain loops was provided by interspecies comparisons of IgA. Thus a human IgA1 mutant, LA441-442MN, which mimicked the mouse IgA loop sequence through substitution of two adjacent residues in the Calpha3 loop, was found, like mouse IgA, not to bind CD89. In contrast, bovine IgA1, identical to human IgA1 within these interdomain loops despite numerous differences elsewhere in the Fc region, did bind CD89. We have thus identified motifs in the interdomain region of IgA Fc critical for FcalphaR binding and triggering, significantly enhancing present understanding of the molecular basis of the IgA-FcalphaR interaction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438530     DOI: 10.1074/jbc.274.33.23508

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Cleavage of a recombinant human immunoglobulin A2 (IgA2)-IgA1 hybrid antibody by certain bacterial IgA1 proteases.

Authors:  B W Senior; J I Dunlop; M R Batten; M Kilian; J M Woof
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential.

Authors:  Michelle M Gomes; Andrew B Herr
Journal:  Springer Semin Immunopathol       Date:  2006-10-17

3.  Antigen binding to secretory immunoglobulin A results in decreased sensitivity to intestinal proteases and increased binding to cellular Fc receptors.

Authors:  Mélanie Duc; Finn-Eirik Johansen; Blaise Corthésy
Journal:  J Biol Chem       Date:  2009-11-12       Impact factor: 5.157

Review 4.  Role of IgA and IgA fc receptors in inflammation.

Authors:  Renato C Monteiro
Journal:  J Clin Immunol       Date:  2009-10-16       Impact factor: 8.317

Review 5.  Immunoglobulin A: A next generation of therapeutic antibodies?

Authors:  Jantine E Bakema; Marjolein van Egmond
Journal:  MAbs       Date:  2011-07-01       Impact factor: 5.857

6.  Interaction of human, rat, and mouse immunoglobulin A (IgA) with Staphylococcal superantigen-like 7 (SSL7) decoy protein and leukocyte IgA receptor.

Authors:  Bruce D Wines; Paul A Ramsland; Halina M Trist; Sandra Gardam; Robert Brink; John D Fraser; P Mark Hogarth
Journal:  J Biol Chem       Date:  2011-07-22       Impact factor: 5.157

7.  FcαRI binding at the IgA1 CH2-CH3 interface induces long-range conformational changes that are transmitted to the hinge region.

Authors:  Monica T Posgai; Sam Tonddast-Navaei; Manori Jayasinghe; George M Ibrahim; George Stan; Andrew B Herr
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-04       Impact factor: 11.205

8.  Assessment of the neutrophilic antibody-dependent respiratory burst (ADRB) response to Plasmodium falciparum.

Authors:  Stephanie Kapelski; Torsten Klockenbring; Rainer Fischer; Stefan Barth; Rolf Fendel
Journal:  J Leukoc Biol       Date:  2014-08-12       Impact factor: 4.962

9.  Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding.

Authors:  Michelle M Gomes; Stephanie B Wall; Kazuo Takahashi; Jan Novak; Matthew B Renfrow; Andrew B Herr
Journal:  Biochemistry       Date:  2008-10-01       Impact factor: 3.162

10.  Characterization of the horse (Equus caballus) IGHA gene.

Authors:  Bettina Wagner; Irene Greiser-Wilke; Douglas F Antczak
Journal:  Immunogenetics       Date:  2003-10-15       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.